The effect of cyclophosphamide on fas-mediated apoptosis

Journal of Korean Medical Science

Volumn 12, Issue 3, 1997, Pages 185-189

  Lee, Ju Hie ^a   Park, Jae Hoon ^a   Yang, Moon Ho ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Anti cancer drug; Anti Fas; Apoptosis; Lymphoma cell line

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; FAS ANTIGEN; IMMUNOGLOBULIN M;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; MOUSE; PHYSIOLOGY; UPREGULATION;

ANIMALS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOGLOBULIN M; JURKAT CELLS; MICE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031154816     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1997.12.3.185     Document Type: Article

References (20)

1. Wyllie AH. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (London) 1980 ; 284 : 555-6.
2. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994 ; 73 : 2013-26.
3. Yonehara S, Ishii A, Yonehara M. A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989 ; 169 : 1747-56.
4. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH. Mononoclonal antibody mediated tumor regression by induction of apoptosis. Science 1989 ; 245 : 301-5.
5. Ito N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen fas can mediate apoptosis. Cell 1991 ; 66 : 233-43.
6. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH. Induction of apoptosis by monoclonal antibody anti-APO-1 class swith variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 1992 ; 149 : 3166-73.
7. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994 ; 78 : 539-42.
8. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990 ; 40 : 2353-62.
9. Dive C, Hickman JA. Drug -target interactions : only the first step in the commitment to a programmed cell death ? Br J Cancer 1991 ; 64 : 192-6.
10. Bosanquet AG. An assessment of a short term chemosensitivity assay in chronic lymphocytic leukemia. Br J Cancer 1983 ; 47 : 781-9.
11. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, Nagata S. Fas meditated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 1994 ; 215 : 332-7.
12. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Ngata S. Lethal effect of the anti-Fas Ab in mice. Nature 1993 ; 364 : 806-9.
13. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S. Anti-fas monoclonal Ab is cytocidal to HIV infected cells without augmenting viral replication. Proc Natl Acad Sci USA 1990 ; 87 : 9620-4.
14. Morimoto H, Yonehara S, Bonavida B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res 1993 ; 53 : 2591-6.
15. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995 ; 86 : 883-9.
16. Park JH, Yang MH. Induction of Fas antigen expressions and apoptosis by cytotoxic drugs in tumor cell lines. Korean J Pathol 1995 ; 29 (suppl) : A89.
17. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N. Differential expression of apoptosis related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992 ; 149 : 3753-8.
18. Zhang J, Winoto A. A mouse Fas-associated protein with homology to the human Mortl/FADD protein is essential for Fas-induced apoptosis. Mol Cell Biol 1996 ; 16 : 2756-63.
19. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993 ; 75 : 1169-78.
20. Friesen C, Herr I, Krammer PH, Debatin KM. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med 1996 ; 2 : 574-7.